BY4 (Primaquine Phosphate 15mg (base))

Pill with imprint BY4 is Purple, Round and has been identified as Primaquine Phosphate 15mg (base). It is supplied by Bayshore Pharmaceuticals, LLC.

Primaquine is used in the treatment of pneumocystis pneumonia; malaria; malaria prevention and belongs to the drug class antimalarial quinolines. FDA has not classified the drug for risk during pregnancy. Primaquine 15mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for BY4

Primaquine Phosphate

Imprint: BY4
Strength: 15mg (base)
Color: Purple
Shape: Round
Availability: Prescription only
Drug Class: Antimalarial quinolines
Pregnancy Category: N - Not classified
CSA Schedule: Not a controlled drug
Labeler / Supplier: Bayshore Pharmaceuticals, LLC
National Drug Code (NDC): 60429-0035
Inactive Ingredients: microcrystalline cellulose, corn starch, lactose monohydrate, magnesium stearate, water, titanium dioxide, FD&C Red No. 40, FD&C Blue No. 2
Note: Inactive ingredients may vary.